Monitor measures early signs of pulmonary oedema:
This article was originally published in Clinica
Israeli company RS Medical Monitoring has developed a device to monitor patients for early signs of pulmonary oedema, a potentially fatal complication associated with acute heart disease. The monitor, which measures changes in the active resistance in the lungs caused by an accumulation of fluids, gives an audio-visual signal if the fluid level exceeds or falls below pre-set levels.
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.